Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

Author(s): D. Digiuseppe, C. Feliciani

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents

Volume 8 , Issue 1 , 2009

Become EABM
Become Reviewer
Call for Editor


Psoriasis has been for a long time a distressing skin disease difficult to treat. Several topical and systemic drugs have been used successfully in the treatment but the most active drugs are also the most difficult to manage in a long term treatment. Discovering the pathogenesis of this skin disorder has suggested that anti tumor necrosis factors agents could be an alternative treatment. Up to now several manuscripts show data supporting the idea that anti TNF are safe and effective more than other drugs. On the experience of dermatologists using this drug in a large number of patients TNF inhibitors are very effective drugs with a relatively safe management. At the moment several drug companies are developing a second generation of biologic drugs with different targets. This review point out the actual knowledge about anti TNF drugs and their activities on psoriasis both clinically and biologically.

Keywords: Psoriasis, therapy, anti TNF, biological agents, tumor necrosis factor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [47 - 50]
Pages: 4
DOI: 10.2174/187152309787580766

Article Metrics

PDF: 15